🇺🇸 FDA
Patent

US 10487140

Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins

granted A61KA61K38/00A61P

Quick answer

US patent 10487140 (Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins) held by INTEGRATED BIOTHERAPEUTICS, INC. expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INTEGRATED BIOTHERAPEUTICS, INC.
Grant date
Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K38/00, A61P, A61P11/00, A61P31/04